View PDF Version - RePub - Erasmus Universiteit Rotterdam

6 References
Aaltonen LA, Peltomiiki P, Leach FS, Sistonen P, Pylkkiinen L, Mecklin JP, Jarvinen H, Powell SM et .11.
(1993) Clues to the pathogenesis of familial colorectal cancer. Science 260:812-816.
Ahuja HO, Foti A. Zhau DJ, Cline MJ (1990) Analysis of proto-oncogenes in acute myeloid leukemia: loss of
heterozygosity fOT the Ha-ras gene. Blood 75:819-822
Ali lV, Liderau R. 111eiIJel C, Callahan R (1987) Reduction to homozygosity of genes on chromosome 11 in
human breast neoplasia. Science 238: 185-188.
AI-Rodhan NRF. Laws ER (1990) Meningioma: A historical study of the tumor and its surgical management.
Neurosurg 26:832-847.
AI-Saadi A, Latimer F. Madercic M, Robbins T (1987) Cytogenetic studies of human brain tUmors and their
clinical significance, Cancer Genet Cytogenet 26: 127-141.
Andersen LB, Fountain JW, Gutmann DR, Tarle SA, Glover TW, Dracopoli NC. Housman DE, Collins FS
(1993) Mutations in the neurofibromatosis t gene in sporadic malignant melanoma cell lines, Nature Genet
3:I18-121.
Arakawa H, Hayashi N, Nagase H, Ogawa M, Nakamura Y (1994) Alternative splicing of the NF2 gene and
its mutation analysis of breast ami coloredal cancers, Hum Mol Oen 3:565-568,
Arinami T, Kondo I, Hamaguchi H, Nakajima S (1986) Multifocal meningiomas in a patient with a
constitutional ring chromosome 22, J Med Genet 23:178-180,
Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup M, van Tuinen P et al. (1989)
Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas, Science 244:217-221.
Baker SJ, Markowitz S, Fearon ER. Willson JK, Vogelstein B (1990) Suppression of human coloreclal
carcinoma cell growth by wild-type p53, Science 249:912-915_
Bartek I, Bartkova J, Vojtesek B, Staskova Z, Lukas J, Rejthar A, Kovarik J et al. (1991) Aberrant expression
of the p53 oncoprotein is a common feature ofa wide spectrum of human malignancies_ Oncogene 6: 1699-1703,
Beckwith JB, Kiviat NB, Bondio JF (1990) Nephrogenic resls, nephroblaslomatosis, and the pathogenesis of
Wilms' tumor_ Pediatr PathoI1O:1-36.
Bianchi AB. Hara T, Ramesh V, Gao J, Klein-Szanto AlP, Morin F, Menon AG et al. (1994) Mutations in
transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nature Genet 6: 185· 192.
Biegel JA, Rorke LB, Packer RJ, Emanuel BS (1990) Monosomy 22 in rhabdoid or atypical tumors of the
brain. J Neurosurg 73:710-714.
Biegel JA, Burk CD, Parmiter AH, Emanuel BS (1992) Molecular analysis of a partial deletion of 22q in a
central nervous system rhabdoid tumor. Genes Chrom Cancer 5:104·108.
van Biezen NA, Lekanne Deprez RH, Thijs A, Heutink P, Oostra BA, Geurts van Kessel ARM, ZwarthoffEC
(1993) Isolation and characterization of25 unique DNA markers for human chromosome 22. Genomics 15:206·
208.
BischoffJR, Friedman PN, Marshak DR, Prives C, Beach D. (1990) Human p53 is phosphorylated by p60-cde2
and cyetin B·cdc2. Proc Natl Acad Sci USA 87:4766·4770.
Black P McL (1991) Brain Tumors. New Engl J Med 324:1555-1564.
BoUag G, McCormick F (1992) NF is enough of GAP. Nature 356:663·664.
Bongarzone I, Monzini N, Borrello MG, Carcano C, Ferraresi G, Arighi E, Mondellini P et al. (1993)
Molecular characterization of a thyroid tumor-specific transforming sequence fonned by the fusion of ret
tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A. Mol Cell Bioi
13:358-366.
Bookstein R, Rio P, Madreperla SA, Hong F, Allred C, Grizzle WE, Lee WH (l990a) Promoter deletion and
loss of retinoblastoma gene expression in human prostate carcinoma. Proc Nat! Acad Sci USA 87:7762-7766.
41